Apax Global Fund says Apax IX to sell Healthium MedTech interest

(Alliance News) - Apax Global Alpha Ltd on Tuesday said that an affiliate of the Apax IX fund ...

Alliance News 7 May, 2024 | 9:57AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Apax Global Alpha Ltd on Tuesday said that an affiliate of the Apax IX fund will sell its controlling interest in Healthium MedTech Ltd.

Apax Global Alpha is a London-based investment trust. It is a limited partner of the Apax IX fund.

AGA said that the deal values its look-through investment in Healthium at around EUR22.7 million, a 23% increase to the last unaffected valuation and an uplift of EUR4.3 million in the adjusted net asset value of AGA at March 31.

Healthium is a Bangalore, India-based medical devices company.

Shares in Apax Global Alpha were down 0.6% at 148.80 pence per share on Tuesday morning.

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Apax Global Alpha Ord 153.80 GBX 1.85

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures